2021
The protective effect of metformin against testicular damage in diabetes and prostate cancer model
Abstract: Individuals with diabetes have an increased risk of breast, colorectal, pancreatic and prostate cancer. Metformin, an oral biguanide used to treat diabetes, has anti-hyperglycaemic, anti-hyperinsulinemic and antioxidant activities. The effects of metformin on testicular tissue damage in cancer and diabetic + cancer rat models were evaluated histologically, immunohistochemically and biochemically. The diabetic model was produced in Copenhagen rats using a single dose of streptozotocin (65 mg/kg), while prostate…
Search citation statements
Paper Sections
Select...
13
5
2
0
Citation Types
1
13
0
0
Year Published
Range
2021
2026
Publication Types
Select...
17
Relationship
1
16
Authors
Journals
Cited by 17 publications
(14 citation statements)
References 49 publications
1
13
0
0
Smart CitationsHow the paper below cites the one you are viewing
“…In the present study, the significant decrease in SOD activity and GSH levels, along with the marked elevation in MDA levels in the diabetic group, confirms the presence of oxidative stress-mediated testicular damage in diabetes. Similar findings have been reported in previous studies, where hyperglycemia induced excessive reactive oxygen species (ROS) production, leading to the depletion of enzymatic (SOD, CAT, GPx) and nonenzymatic (GSH) antioxidants, while accelerating lipid peroxidation as indicated by increased MDA concentrations (Elshafey et al 2023;Koroglu Aydin et al 2022). In agreement with our results, importantly, in our study, treatment with AgNP+18β-GA effectively prevented the decline in SOD and GSH, while suppressing MDA accumulation.…”
Section: Discussion
supporting
confidence: 87%
Abstract